Influence of NMO gut microbiota on CNS autoantigen-specific T cell responses
NMO 肠道微生物群对 CNS 自身抗原特异性 T 细胞反应的影响
基本信息
- 批准号:9766417
- 负责人:
- 金额:$ 20.52万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-09-01 至 2020-08-31
- 项目状态:已结题
- 来源:
- 关键词:Adenosine TriphosphateAdjuvantAmino Acid SequenceAnaerobic BacteriaAntibodiesAstrocytesAutoantigensAutoimmune DiseasesAutoimmune Diseases of the Nervous SystemAutoimmune ProcessBacteriaBindingCNS autoimmunityCellsCharacteristicsClinicalClostridiumClostridium perfringensDemyelinating DiseasesDevelopmentEpitopesEquilibriumExhibitsGastrointestinal tract structureGerm-FreeGram-Positive BacteriaHouseholdHumanIgG1InflammatoryLinkMultiple SclerosisMusNeuraxisNeuromyelitis OpticaPathogenesisPathologicPatientsPredispositionProcessProteinsRegulatory T-LymphocyteResearchRoleT cell differentiationT cell responseT-LymphocyteT-Lymphocyte EpitopesTaxonTestingantigen-specific T cellsaquaporin 4basecross reactivitygut microbiomegut microbiotamultiple sclerosis patientpeptide permeasepermeaseprogramsresponsewater channel
项目摘要
PROJECT SUMMARY / ABSTRACT
Neuromyelitis optica (NMO) is a rare, disabling and sometimes fatal, central nervous system (CNS) autoimmune
inflammatory demyelinating disease. Aquaporin-4 (AQP4), a water channel that is expressed abundantly on astrocytes, is
the primary target in NMO. A majority of NMOSD patients have AQP4-specific Abs, which are IgG1, a T cell-dependent
subclass, indicating that AQP4-specific T cells have a key role in this humoral autoimmune disease. Certain clinical and
pathologic findings suggest that Th17 cells participate in NMO pathogenesis. Our group first identified AQP4-specific T
cells, an observation that was confirmed by other groups. We observed that T cells specific for dominant AQP4 epitopes
exhibited Th17 polarization, providing further support that Th17 cells participate in NMO pathogenesis. Further, the
dominant AQP4 T cell epitope identified in NMO contains a ten amino acid (aa) sequence that shares 90% homology to an
aa sequence within an ABC-TP in Clostridium perfringens, a ubiquitous anaerobic gram-positive bacterium found in human
commensal gut flora. This discovery, along with the demonstration that certain Clostridia species in the gut of humans can
regulate the balance between regulatory T cells (Treg) and Th17 cells, suggest that gut microbiota, and possibly C.
perfringens itself, could participate in NMO pathogenesis.
Recently, we evaluated the gut microbiome in NMO, multiple sclerosis (MS) and healthy controls (HC). Remarkably,
C. perfringens was the second most significantly enriched taxon in NMO, and among bacteria identified at the species level,
C. perfringens was the one most highly associated with NMO. Thus, we have hypothesized that C. perfringens may have
dual functions in NMO pathogenesis: it may (1) serve as its own proinflammatory adjuvant, promoting Th17 polarization,
and (2) expose a determinant of a Clostridium ABC-TP that cross-reacts with AQP4, leading to expansion of AQP4-reactive
T cells. Here, we propose to colonize germ-free mice with gut microbiota from NMO patients or by mono-colonization with
C. perfringens, in order to directly examine the potential role of gut microbiota in NMO and C. perfringens, respectively,
in proinflammatory T cell differentiation. In the process of examining our hypothesis regarding C. perfringens, our study
should provide important information regarding the potential role of gut microbiota in NMO and CNS autoimmunity in
general.
项目总结/摘要
视神经肌萎缩症(NMO)是一种罕见的,致残的,有时是致命的,中枢神经系统(CNS)的自身免疫性疾病。
炎性脱髓鞘疾病水通道蛋白-4(AQP 4)是一种在星形胶质细胞上大量表达的水通道,
NMO的主要目标大多数NMOSD患者具有AQP 4特异性抗体,其为IgG 1,一种T细胞依赖性抗体。
亚类,表明AQP 4特异性T细胞在这种体液自身免疫性疾病中具有关键作用。某些临床和
病理结果提示Th 17细胞参与了NMO的发病过程。我们的小组首先确定了AQP 4特异性T细胞,
细胞,这一观察得到了其他团体的证实。我们观察到对优势AQP 4表位特异的T细胞
显示Th 17极化,进一步支持Th 17细胞参与NMO发病机制。此夕h
在NMO中鉴定的显性AQP 4 T细胞表位含有10个氨基酸(aa)序列,其与在NMO中鉴定的AQP 4 T细胞表位具有90%同源性。
产气荚膜梭菌ABC-TP中的aa序列,产气荚膜梭菌是一种普遍存在于人体中的厌氧革兰氏阳性菌
肠道植物群。这一发现,沿着的是人类肠道中的某些梭菌物种可以
调节调节性T细胞(Treg)和Th 17细胞之间的平衡,表明肠道微生物群,可能还有C.
产气荚膜杆菌本身可能参与NMO的发病。
最近,我们评估了NMO,多发性硬化症(MS)和健康对照(HC)的肠道微生物组。值得注意的是,
C.产气荚膜杆菌是NMO中第二个最显著富集的分类群,并且在物种水平上鉴定的细菌中,
C.产气荚膜杆菌是与NMO相关性最高的一种。因此,我们假设C。产气荚膜杆菌可能具有
在NMO发病机制中的双重功能:它可以(1)作为其自身的促炎佐剂,促进Th 17极化,
和(2)暴露与AQP 4交叉反应的梭菌ABC-TP的决定子,导致AQP 4反应性的扩增,
T细胞。在这里,我们建议用来自NMO患者的肠道微生物群或通过以下单定植来定植无菌小鼠:
C.产气荚膜梭菌,以直接检查肠道微生物群在NMO和C.产气荚膜杆菌,分别,
在促炎性T细胞分化中的作用在检验我们关于C.产气荚膜杆菌,我们的研究
应该提供关于肠道微生物群在NMO和CNS自身免疫中的潜在作用的重要信息,
将军
项目成果
期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Publisher Correction: B cells in autoimmune and neurodegenerative central nervous system diseases.
出版商更正:自身免疫性和神经退行性中枢神经系统疾病中的 B 细胞。
- DOI:10.1038/s41583-019-0251-0
- 发表时间:2020
- 期刊:
- 影响因子:0
- 作者:SabatinoJr,JosephJ;Pröbstel,Anne-Katrin;Zamvil,ScottS
- 通讯作者:Zamvil,ScottS
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SCOTT S ZAMVIL其他文献
SCOTT S ZAMVIL的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SCOTT S ZAMVIL', 18)}}的其他基金
Characterization of T cells in MOG antibody-associated disease
MOG 抗体相关疾病中 T 细胞的表征
- 批准号:
10737097 - 财政年份:2023
- 资助金额:
$ 20.52万 - 项目类别:
Repertoire selection of AQP4-specific T cells that cause CNS autoimmunedisease
引起中枢神经系统自身免疫性疾病的 AQP4 特异性 T 细胞的库选择
- 批准号:
10303022 - 财政年份:2018
- 资助金额:
$ 20.52万 - 项目类别:
Repertoire selection of AQP4-specific T cells that cause CNS autoimmunedisease
引起中枢神经系统自身免疫性疾病的 AQP4 特异性 T 细胞的库选择
- 批准号:
10059165 - 财政年份:2018
- 资助金额:
$ 20.52万 - 项目类别:
Repertoire selection of AQP4-specific T cells that cause CNS autoimmunedisease
引起中枢神经系统自身免疫性疾病的 AQP4 特异性 T 细胞的库选择
- 批准号:
10520039 - 财政年份:2018
- 资助金额:
$ 20.52万 - 项目类别:
Regulatory monocytes in CNS autoimmune disease
中枢神经系统自身免疫性疾病中的调节性单核细胞
- 批准号:
8289576 - 财政年份:2009
- 资助金额:
$ 20.52万 - 项目类别:
Regulatory monocytes in CNS autoimmune disease
中枢神经系统自身免疫性疾病中的调节性单核细胞
- 批准号:
8084129 - 财政年份:2009
- 资助金额:
$ 20.52万 - 项目类别:
相似海外基金
Metachronous synergistic effects of preoperative viral therapy and postoperative adjuvant immunotherapy via long-term antitumor immunity
术前病毒治疗和术后辅助免疫治疗通过长期抗肿瘤免疫产生异时协同效应
- 批准号:
23K08213 - 财政年份:2023
- 资助金额:
$ 20.52万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Improving the therapeutic immunity of cancer vaccine with multi-adjuvant polymeric nanoparticles
多佐剂聚合物纳米粒子提高癌症疫苗的治疗免疫力
- 批准号:
2881726 - 财政年份:2023
- 资助金额:
$ 20.52万 - 项目类别:
Studentship
Evaluation of the Sensitivity to Endocrine Therapy (SET ER/PR) Assay to predict benefit from extended duration of adjuvant endocrine therapy in the NSABP B-42 trial
NSABP B-42 试验中内分泌治疗敏感性 (SET ER/PR) 测定的评估,用于预测延长辅助内分泌治疗持续时间的益处
- 批准号:
10722146 - 财政年份:2023
- 资助金额:
$ 20.52万 - 项目类别:
Countering sympathetic vasoconstriction during skeletal muscle exercise as an adjuvant therapy for DMD
骨骼肌运动期间对抗交感血管收缩作为 DMD 的辅助治疗
- 批准号:
10735090 - 财政年份:2023
- 资助金额:
$ 20.52万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 20.52万 - 项目类别:
DEVELOPMENT OF SAS A SYNTHETIC AS01-LIKE ADJUVANT SYSTEM FOR INFLUENZA VACCINES
流感疫苗类 AS01 合成佐剂系统 SAS 的开发
- 批准号:
10935776 - 财政年份:2023
- 资助金额:
$ 20.52万 - 项目类别:
DEVELOPMENT OF SMALL-MOLECULE DUAL ADJUVANT SYSTEM FOR INFLUENZA VIRUS VACCINE
流感病毒疫苗小分子双佐剂体系的研制
- 批准号:
10935796 - 财政年份:2023
- 资助金额:
$ 20.52万 - 项目类别:
A GLYCOLIPID ADJUVANT 7DW8-5 FOR MALARIA VACCINES
用于疟疾疫苗的糖脂佐剂 7DW8-5
- 批准号:
10935775 - 财政年份:2023
- 资助金额:
$ 20.52万 - 项目类别:
Adjuvant strategies for universal and multiseasonal influenza vaccine candidates in the context of pre-existing immunity
在已有免疫力的情况下通用和多季节流感候选疫苗的辅助策略
- 批准号:
10649041 - 财政年份:2023
- 资助金额:
$ 20.52万 - 项目类别:
Adjuvant Photodynamic Therapy to Reduce Bacterial Bioburden in High-Energy Contaminated Open Fractures
辅助光动力疗法可减少高能污染开放性骨折中的细菌生物负载
- 批准号:
10735964 - 财政年份:2023
- 资助金额:
$ 20.52万 - 项目类别: